Teavigo (Epigallocatechin gallate)

Teavigo is a standardized extract of epigallocatechin gallate (EGCG), the primary bioactive catechin found in green tea. It works by modulating cellular antioxidant pathways and lipid metabolism through inhibition of fatty acid synthase and activation of AMP-activated protein kinase.

Origin & History

Teavigo is a branded, purified green tea extract standardized to minimum 94% epigallocatechin gallate (EGCG), derived from Camellia sinensis leaves. It is produced caffeine-free through a multi-step process including water extraction, ethyl acetate extraction, chromatography, crystallization, and drying to yield a water-soluble powder.

Historical & Cultural Context

EGCG derives from green tea (Camellia sinensis), used for centuries in Traditional Chinese Medicine for antioxidant, digestive, and vitality benefits. However, Teavigo itself is a modern branded extract without historical precedent.

Health Benefits

• Weight management support - Preclinical evidence shows prevention and regression of diet-induced obesity through lipid metabolism regulation in adipose tissue
• Antioxidant cellular protection - EGCG acts as a potent antioxidant protecting cells from oxidative damage
• Cardiovascular health support - Contributes to heart health through polyphenol activity (mechanism-based evidence)
• Anti-parasitic activity - Inhibits hexose uptake in infected cells by binding adhesion molecules, impairing parasite energy production
• Cancer cell growth inhibition - Induces apoptosis in cancer cell lines like HT29 colorectal cells, with synergistic effects when combined with epicatechin

How It Works

EGCG inhibits fatty acid synthase (FAS) enzyme activity, reducing lipogenesis in adipose tissue while activating AMP-activated protein kinase (AMPK) to enhance fat oxidation. The compound's polyphenolic structure provides antioxidant protection by scavenging reactive oxygen species and chelating metal ions. EGCG also modulates nitric oxide synthase activity and inhibits angiotensin-converting enzyme (ACE) to support cardiovascular function.

Scientific Research

The primary evidence comes from a preclinical study in C57BL/6J mice and Sprague-Dawley rats demonstrating obesity prevention through Teavigo supplementation, with gene expression analysis confirming lipid metabolism regulation (PMID: 15735368). No human randomized controlled trials specifically using the Teavigo brand were identified in the available research.

Clinical Summary

Preclinical studies demonstrate EGCG's ability to prevent and reverse diet-induced obesity through metabolic regulation in adipose tissue. Human trials with green tea extracts containing 200-400mg EGCG show modest weight loss effects of 2-4 pounds over 8-12 weeks. Antioxidant benefits are well-documented in cell culture and animal studies, though human clinical data remains limited. Cardiovascular benefits are primarily supported by observational studies and short-term intervention trials showing improvements in endothelial function.

Nutritional Profile

Teavigo is a highly purified EGCG (Epigallocatechin gallate) extract standardized to ≥94% EGCG content, derived from green tea (Camellia sinensis). As a concentrated polyphenol isolate, it contains negligible macronutrients (carbohydrates, fats, proteins) at typical supplemental doses. Primary bioactive compound: EGCG (a catechin-class flavan-3-ol) at ≥94% purity per DSM specification, with trace amounts of other green tea catechins including EGC (epigallocatechin), ECG (epicatechin gallate), and EC (epicatechin) comprising the remaining ~6%. Typical supplemental doses range from 100–400 mg EGCG per serving. No meaningful vitamin, mineral, or fiber content is present at these doses. Bioavailability notes: EGCG has inherently limited oral bioavailability (~1–5% absorption in humans) due to poor intestinal permeability, rapid phase II metabolism (glucuronidation, sulfation, methylation), and degradation at intestinal pH. Peak plasma concentrations (Cmax) following a 400 mg dose are approximately 0.5–1.0 µmol/L. Absorption is enhanced in a fasted state; food co-ingestion can reduce Cmax by up to 60%. The gallate moiety on EGCG contributes to its potent antioxidant activity but also limits transport across epithelial membranes. No significant caloric contribution at standard doses (<5 kcal per serving).

Preparation & Dosage

Products typically deliver 150 mg Teavigo per serving (yielding approximately 141 mg EGCG at 94% standardization). Animal studies used obesity-preventing doses, but specific human dosage ranges are not established in the research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Epicatechin, Vitamin C, Quercetin, Piperine, Omega-3 fatty acids

Safety & Interactions

EGCG supplements are generally well-tolerated at doses up to 800mg daily, though higher doses may cause nausea, stomach upset, or headaches. The compound can enhance the effects of blood-thinning medications like warfarin and may reduce iron absorption when taken with meals. Liver toxicity has been reported with very high doses (1000mg+) of concentrated EGCG supplements, particularly on empty stomach. Pregnant and breastfeeding women should avoid high-dose EGCG supplements due to insufficient safety data.